The relationship between severity of coronary artery disease and mean platelet volume

Автор: Varastehravan Hamidreza, Naghedi Aryan, Nough Hossein, Pourmirafzali Hamideh

Статья в выпуске: 14, 2019 года.

Бесплатный доступ

Aims Increased MPV is a risk factor for cardiovascular diseases and can be associated with coronary artery involvement. In this study, we aimed to investigate the relationship between the severity of coronary artery disease and MPV. Materials and methods In this study, a total of 200 patients with coronary artery disease were enrolled. All patients initially underwent coronary angiography. Plasma TG, LDL, and HDL, was measured using commercial kits Integra 800TM. MPV and platelet count was determined by the Sysmex XT-2000iTM. Population were divided into three groups based on the SYNTAX score: low, moderate and high. All angiographic grading of SYNTAX was carried out by two cardiologists with blinded clinical data. After Data collection, these data were entered to SPSS22 software and were analyzed using correlation coefficient regression analysis. Results A total of 200 patients entered to the study that 43% and 57 % of patients were female and male, respectively. eighty-seven patients were diabetic and other 113 patients were not diabetic...

Еще

Mean platelet volume, syntax score, coronary artery, risk factor

Короткий адрес: https://sciup.org/148308868

IDR: 148308868 | DOI: 10.12710/cardiometry.2019.14.5763

Список литературы The relationship between severity of coronary artery disease and mean platelet volume

Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clinical cornerstone. 2008;9(2):24-41.
Shirani G, Morovati SP, Shamshiri AR, Nouri M, Givi NE, Farhadi M. Prevalence of Cardiovascular Disorders in Iranian Patients Suffering from Obstructive Sleep Apnea. Journal of dentistry (Tehran, Iran). 2016;13(3):151.
Hatmi Z, Tahvildari S, Motlag AG, Kashani AS. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular disorders. 2007;7(1):32.
Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Mancia G, de Leeuw PW, et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. Journal of hypertension. 2002;20(10):1973-80.
Nanchahal K, Durrington PN, Jackson RT. Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000. Bmj. 2002;325(7357):194-5.
Roger VL. Epidemiology of myocardial infarction. Medical Clinics. 2007;91(4):537-52.
Shi G, Morrell CN. Platelets as initiators and mediators of inflammation at the vessel wall. Thrombosis research. 2011;127(5):387-90.
Gros A, Ollivier V, Ho-Tin-Noé B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Frontiers in immunology. 2015;5:678.
Ebrahimi M, Kazemi-Bajestani S, Ghayour-Mobarhan M, Ferns G. Coronary artery disease and its risk factors status in Iran: a review. Iranian Red Crescent Medical Journal. 2011;13(9):610.
Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-41 DOI: 10.1038/35025203
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine. 2014;5(8):927.
Singh RB, Mengi SA, Xu Y-J, Arneja AS, Dhalla NS. Pathogenesis of atherosclerosis: A multifactorial process. Experimental & Clinical Cardiology. 2002;7(1):40.
Watkins LO. Epidemiology and burden of cardiovascular disease. Clinical cardiology. 2004;27(S3):2-6.
Tan YY, Gast G-CM, van der Schouw YT. Gender differences in risk factors for coronary heart disease. Maturitas. 2010;65(2):149-60.
Bath P, Butterworth R. Platelet size: measurement, physiology and vascular disease. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis. 1996;7(2):157-61.
Martin J, Trowbridge E, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thrombosis research. 1983;32(5):443-60.
Estévez-Loureiro R, Salgado-Fernández J, Marzoa-Rivas R, Barge-Caballero E, Pérez-Pérez A, Noriega-Concepción V, et al. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thrombosis research. 2009;124(5):536-40.
Kostrubiec M, Łabyk A, Pedowska-Włoszek J, Hrynkiewicz-Szymańska A, Pacho S, Jankowski K, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart. 2010;96(6):460-5.
Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology. 1998;31(2):352-8.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine. 2005;352(16):1685-95.
Martin J, Bath P, Burr M. Influence of platelet size on outcome after myocardial infarction. The Lancet. 1991;338(8780):1409-11.
Halbmayer W-M, Haushofer A, Radek J, Schön R, Deutsch M, Fischer M. Platelet size, fibrinogen and lipoprotein (a) in coronary heart disease. Coronary artery disease. 1995;6(5):397-402.
Smyth D, Martin J, Michalis L, Bucknall C, Jewitt D. Influence of platelet size before coronary angioplasty on subsequent restenosis. European journal of clinical investigation. 1993;23(6):361-7.
Fateh-Moghadam S, Bocksch W, Ruf A, Dickfeld T, Schartl M, Pogátsa-Murray G, et al. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation. 2000;102(8):890-7.
Fateh-Moghadam S, Li Z, Ersel S, Reuter T, Htun P, Plöckinger U, et al. Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arteriosclerosis, thrombosis, and vascular biology. 2005;25(6):1299-303.
Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thrombosis and haemostasis. 2003;89(06):1112-20.
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103(6):2096-104
De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206(1):292-7.
Tavil Y, Sen N, Hızal F, Abacı A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thrombosis research. 2007;120(2):245-50.
Tufano A, Cimino E, Di Minno M, Ierano P, Marrone E, Strazzullo A, et al. Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. International journal of vascular medicine. 2011;2011.
Ekici B, Erkan AF, Alhan A, Sayin I, Ayli M, Töre HF. Is mean platelet volume associated with the angiographic severity of coronary artery disease? Kardiologia Polska (Polish Heart Journal). 2013;71(8):832-8.
Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Annals of internal medicine. 1994;121(9):641-7
Davoodi G, Pari SM, Rezvanfard M, Fathollahi MS, Amini M, Hakki E, et al. Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography. International urology and nephrology. 2012;44(4):1161-8
Nunes JPL, Faria MdS, Garcia J, Gonçalves FR. Glomerular filtration rate and coronary artery disease burden in patients with acute coronary syndrome. Clinical cardiology. 2007;30(9):464-8
Doganer YC, Rohrer JE, Aydogan U, Bernard ME, Barcin C. Haemoglobin levels correlates with the presence of coronary artery disease. Journal of evaluation in clinical practice. 2015;21(5):937-42.
Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Ruocco MV, Perrone-Filardi P, et al. Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus. American journal of preventive medicine. 2014;47(1):9-16.
Shah AD, Nicholas O, Timmis AD, Feder G, Abrams KR, Chen R, et al. Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS medicine. 2011;8(5):e1000439.

Еще

Статья научная